JP2023513419A5 - - Google Patents

Info

Publication number
JP2023513419A5
JP2023513419A5 JP2022544153A JP2022544153A JP2023513419A5 JP 2023513419 A5 JP2023513419 A5 JP 2023513419A5 JP 2022544153 A JP2022544153 A JP 2022544153A JP 2022544153 A JP2022544153 A JP 2022544153A JP 2023513419 A5 JP2023513419 A5 JP 2023513419A5
Authority
JP
Japan
Prior art keywords
alkyl
membered
ring
cancer
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022544153A
Other languages
English (en)
Japanese (ja)
Other versions
JP7688646B2 (ja
JP2023513419A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/073169 external-priority patent/WO2021147974A1/en
Publication of JP2023513419A publication Critical patent/JP2023513419A/ja
Publication of JP2023513419A5 publication Critical patent/JP2023513419A5/ja
Application granted granted Critical
Publication of JP7688646B2 publication Critical patent/JP7688646B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022544153A 2020-01-22 2021-01-22 オーロラa選択的阻害剤として有用な新規複素環式化合物 Active JP7688646B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN2020073786 2020-01-22
CNPCT/CN2020/073786 2020-01-22
CNPCT/CN2020/076159 2020-02-21
CN2020076159 2020-02-21
CN2020085922 2020-04-21
CNPCT/CN2020/085922 2020-04-21
PCT/CN2021/073169 WO2021147974A1 (en) 2020-01-22 2021-01-22 Novel heterocyclic compounds useful as aurora a selective inhibitors

Publications (3)

Publication Number Publication Date
JP2023513419A JP2023513419A (ja) 2023-03-31
JP2023513419A5 true JP2023513419A5 (enExample) 2024-01-25
JP7688646B2 JP7688646B2 (ja) 2025-06-04

Family

ID=76993163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544153A Active JP7688646B2 (ja) 2020-01-22 2021-01-22 オーロラa選択的阻害剤として有用な新規複素環式化合物

Country Status (13)

Country Link
US (2) US20230128198A1 (enExample)
EP (1) EP4093736A4 (enExample)
JP (1) JP7688646B2 (enExample)
KR (1) KR102828343B1 (enExample)
CN (2) CN114423751B (enExample)
AU (1) AU2021209744B2 (enExample)
CL (1) CL2022001951A1 (enExample)
CO (1) CO2022010878A2 (enExample)
IL (1) IL294247B2 (enExample)
MX (1) MX2022009059A (enExample)
PH (1) PH12022551858A1 (enExample)
TW (1) TWI785474B (enExample)
WO (1) WO2021147974A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA53172A (fr) 2018-07-20 2021-05-26 Hoffmann La Roche Composés de sulfonimidamide en tant qu'inhibiteurs de l'activité de l'interleukine 1
CN112239465A (zh) * 2019-07-16 2021-01-19 微境生物医药科技(上海)有限公司 极光激酶抑制剂及其用途
CN112898292A (zh) 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途
BR112022014480A2 (pt) 2020-01-22 2022-09-13 Hoffmann La Roche Compostos, composições farmacêutica, método para tratar um distúrbio em um paciente, usos de um composto e de uma composição farmacêutica e kit
CN118946560A (zh) * 2022-02-23 2024-11-12 修复治疗公司 Polo样激酶4(plk4)抑制剂、药物组合物、其制备方法和用途
CN115057811B (zh) * 2022-05-26 2024-06-14 安庆朗坤药业有限公司 一种2-溴甲基-3,5-二氟吡啶的制备方法
CN115322143B (zh) * 2022-07-21 2023-07-14 安徽德诺医药股份有限公司 一种4-哌啶甲酸叔丁酯盐酸盐的制备方法
WO2024230647A1 (zh) * 2023-05-05 2024-11-14 苏州信诺维医药科技股份有限公司 杂环类化合物、其药物组合物和其应用
CN116903587B (zh) * 2023-06-01 2024-03-22 三峡大学 一种角鲨烯环氧酶抑制剂及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008081492A (ja) * 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラa選択的阻害作用を有する新規アミノピリジン誘導体
WO2009104802A1 (en) * 2008-02-22 2009-08-27 Banyu Pharmaceutical Co., Ltd. Novel aminopyridine derivatives having aurora a selective inhibitory action
TWI485146B (zh) * 2012-02-29 2015-05-21 Taiho Pharmaceutical Co Ltd Novel piperidine compounds or salts thereof
TWI693218B (zh) * 2014-11-14 2020-05-11 美商美國禮來大藥廠 極光a激酶抑制劑
KR20210084555A (ko) * 2018-11-30 2021-07-07 일라이 릴리 앤드 캄파니 신경모세포종의 치료에 사용하기 위한 오로라 a 키나제 억제제
CN112239465A (zh) * 2019-07-16 2021-01-19 微境生物医药科技(上海)有限公司 极光激酶抑制剂及其用途
CN112898292A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途

Similar Documents

Publication Publication Date Title
JP2001526269A5 (enExample)
JP2001247459A (ja) 癌の組み合わせ療法
JP2001525359A5 (enExample)
CA2440037A1 (en) Benzimidazole derivatives for modulating the rage receptor
CA2708149A1 (en) Combinations of therapeutic agents for treating cancer
EP0527494B1 (en) Compositon containing rhodacyanine dyes for treating cancer
CA2946890A1 (en) Naphthofuran compounds and compositions for targeting cancer stem cells
JP2004517843A5 (enExample)
JP2008500366A5 (enExample)
WO2003074053A1 (en) Use of epothilones in the treatment of brain diseases associated with proliferative processes
JP2024503723A5 (enExample)
RU2004122427A (ru) Пирролидин-2-оны в качестве ингибиторов фактора ха
CN102821605B (zh) 改进的稳定的(e)-4-羧基苯乙烯基-4-氯苄基砜水性制剂
JP2002505276A (ja) 潰瘍用医薬組成物
WO1999018099B1 (en) Aryl thiophene derivatives as pde iv inhibitors
JP4610481B2 (ja) 抗腫瘍効果増強剤及び抗腫瘍剤
RU2208013C2 (ru) ПРОИЗВОДНЫЕ 8-ЗАМЕЩЕННОГО-9H-1,3-ДИОКСОЛ/4,5-h//2,3/БЕНЗОДИАЗЕПИНА, ЯВЛЯЮЩИЕСЯ ИНГИБИТОРАМИ AMPA/КАИНАТНОГО РЕЦЕПТОРА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ
JP2006523233A5 (enExample)
JP2002518506A5 (enExample)
CA1327163C (en) Anxiolytically active piperazine derivatives
US5618831A (en) Composition and method for treating cancer
RU2001124813A (ru) Производные аминометилпирролидина, имеющие ароматические заместители
CN116018146A (zh) 用于治疗高尿酸血症的聚合物、组合物和方法
JPS632925A (ja) Cキナ−ゼ阻害剤および抗腫瘍剤
JP2002505283A (ja) サイトメガロウイルス感染に対する治療的処置